Congressman James Comer plans to investigate the U.S. Food and Drug Administration (FDA), according to the U.S. Hemp Roundtable (USHR), a coalition of companies and organizations that advocate for hemp-friendly regulations.

The Kentucky representative, who is chairman of the U.S. House Oversight Committee, intends to bring FDA Commissioner Robert Califf before the House committee to discuss critical issues falling within the agency’s regulatory jurisdiction such as hemp-derived CBD and medical devices.

“I want to bring the FDA commissioner in …

Full story available on